AVENUE SOLUTIONS for MERCK & CO. INC.
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Antibiotics/stewardship; Value of prescription drugs; H.R. 4127, Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms Act (DISARM Act); S. 2076/H.R. 3932, PASTEUR Act of 2021; Implementation of American Rescue Plan Act of 2021 (P.L. 117-2); Vaccine hesitancy issues; H.R. 5376, Build Back Better Act; Monitor possible healthcare policies in upcoming reconciliation package including: making ACA tax credits/subsidies permanent, adding Medicare enhancements/supplemental benefits (hearing, dental, vision), addressing Medicaid coverage gap, expanding home and community based services, prescription drug reform
| Lobbyist | Covered position, as disclosed |
|---|---|
| TRACY SPICER | — |
Medicare/Medicaid MMM
Issues relating to the further development of antibiotics and antimicrobials for serious and unmet medical needs; Antibiotics/stewardship; H.R. 4127, Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms Act (DISARM Act); S.2076/H.R.3932, PASTEUR Act of 2021; Value of prescription drugs; Issues related to Medicare Parts B and D; Senate Finance Committee Prescription Drug Pricing Reform Principles; Implementation of American Rescue Plan Act of 2021 (PL 117-2); Proposed repeal of the CMS Rule on Most Favored Nation Model; Delay of the Medicare Part D Rebate Rule
| Lobbyist | Covered position, as disclosed |
|---|---|
| TRACY SPICER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.